BlackRock Advisors’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.93M Sell
81,140
-6,753
-8% -$461K 0.01% 1073
2016
Q3
$5.62M Buy
87,893
+1,169
+1% +$71.9K 0.01% 1090
2016
Q2
$4.96M Buy
86,724
+261
+0.3% +$14K 0.01% 1109
2016
Q1
$4.71M Buy
86,463
+781
+0.9% +$37.1K ﹤0.01% 1122
2015
Q4
$4.07M Sell
85,682
-35,013
-29% -$1.71M ﹤0.01% 1161
2015
Q3
$6.14M Sell
120,695
-703
-0.6% -$35.2K 0.01% 1017
2015
Q2
$5.79M Buy
121,398
+81,597
+205% +$3.98M 0.01% 950
2015
Q1
$1.98M Buy
39,801
+24,637
+162% +$1.16M ﹤0.01% 1236
2014
Q4
$732K Sell
15,164
-681
-4% -$31.6K ﹤0.01% 1710
2014
Q3
$635K Sell
15,845
-283
-2% -$12.6K ﹤0.01% 1776
2014
Q2
$795K Sell
16,128
-1,571
-9% -$85.7K ﹤0.01% 1656
2014
Q1
$1.04M Buy
17,699
+954
+6% +$52.4K ﹤0.01% 1501
2013
Q4
$938K Buy
16,745
+956
+6% +$48.1K ﹤0.01% 1552
2013
Q3
$782K Buy
15,789
+512
+3% +$25.1K ﹤0.01% 1587
2013
Q2
$697K Buy
+15,277
New +$635K ﹤0.01% 1581

Other funds holding DORM

BlackRock Advisors's DORM Position: Q4 2016 in Review

BlackRock Advisors reduced its Dorman Products (DORM) stake by 7.7% in Q4 2016, selling an estimated $461K and leaving 81,140 shares worth $5.93M. The position accounts for 0.01% of the portfolio, ranked #1073.

BlackRock Advisors first reported a position in DORM in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.14M in Q3 2015. 233 funds tracked by Wall St. Rank hold DORM as of Q4 2016.

  • BlackRock Advisors held 81,140 shares of Dorman Products worth $5.93M as of Q4 2016.
  • BlackRock Advisors sold 6,753 Dorman Products shares in Q4 2016, an estimated $461K.
  • Dorman Products made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1073 holding.
  • BlackRock Advisors first reported a position in Dorman Products in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Dorman Products position peaked at $6.14M in Q3 2015.
  • 233 funds tracked by Wall St. Rank held Dorman Products as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.